Leukemia, Myelocytic, Acute
|
0.500 |
Biomarker
|
disease |
HPO |
|
|
|
Leukemia, Myelocytic, Acute
|
0.500 |
Biomarker
|
disease |
CTD_human |
|
|
|
Acute Myeloid Leukemia, M1
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
Acute Myeloid Leukemia (AML-M2)
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
Somatic mutation
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Leukemia, Myelocytic, Acute
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
RNA-based polymerase chain reaction analysis revealed identical NPM-MLF1 mRNA fusions in each of the three t(3;5)-positive cases of AML examined.
|
8570204 |
1996 |
Acute Erythroblastic Leukemia
|
0.010 |
Biomarker
|
disease |
BEFREE |
Anti-MLF1 antibodies detected the wild-type 31 kDa protein in K562 and HEL erythroleukemia cell lines, but not in HL-60, U937 or KG-1 myeloid leukemia lines.
|
8570204 |
1996 |
Adult Erythroleukemia
|
0.010 |
Biomarker
|
disease |
BEFREE |
Anti-MLF1 antibodies detected the wild-type 31 kDa protein in K562 and HEL erythroleukemia cell lines, but not in HL-60, U937 or KG-1 myeloid leukemia lines.
|
8570204 |
1996 |
Erythroleukemia (Erythroid/Myeloid)
|
0.010 |
Biomarker
|
disease |
BEFREE |
Anti-MLF1 antibodies detected the wild-type 31 kDa protein in K562 and HEL erythroleukemia cell lines, but not in HL-60, U937 or KG-1 myeloid leukemia lines.
|
8570204 |
1996 |
Leukemia, Myelocytic, Acute
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
A fusion gene between nucleophosmin (NPM) and myelodysplasia/myeloid leukemia factor 1 (MLF1) is formed by a recurrent t(3;5)(q25.1;q34) in myelodysplastic syndrome and acute myeloid leukemia.
|
8661158 |
1996 |
MYELODYSPLASTIC SYNDROME
|
0.080 |
GeneticVariation
|
group |
BEFREE |
A fusion gene between nucleophosmin (NPM) and myelodysplasia/myeloid leukemia factor 1 (MLF1) is formed by a recurrent t(3;5)(q25.1;q34) in myelodysplastic syndrome and acute myeloid leukemia.
|
8661158 |
1996 |
Childhood Myelodysplastic Syndrome
|
0.070 |
GeneticVariation
|
disease |
BEFREE |
A fusion gene between nucleophosmin (NPM) and myelodysplasia/myeloid leukemia factor 1 (MLF1) is formed by a recurrent t(3;5)(q25.1;q34) in myelodysplastic syndrome and acute myeloid leukemia.
|
8661158 |
1996 |
Adult Myelodysplastic Syndrome
|
0.060 |
GeneticVariation
|
disease |
BEFREE |
A fusion gene between nucleophosmin (NPM) and myelodysplasia/myeloid leukemia factor 1 (MLF1) is formed by a recurrent t(3;5)(q25.1;q34) in myelodysplastic syndrome and acute myeloid leukemia.
|
8661158 |
1996 |
Leukemia, Myelocytic, Acute
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
MNDA binds NPM/B23 and the NPM-MLF1 chimera generated by the t(3;5) associated with myelodysplastic syndrome and acute myeloid leukemia.
|
9328447 |
1997 |
MYELODYSPLASTIC SYNDROME
|
0.080 |
GeneticVariation
|
group |
BEFREE |
MNDA binds NPM/B23 and the NPM-MLF1 chimera generated by the t(3;5) associated with myelodysplastic syndrome and acute myeloid leukemia.
|
9328447 |
1997 |
Childhood Myelodysplastic Syndrome
|
0.070 |
GeneticVariation
|
disease |
BEFREE |
MNDA binds NPM/B23 and the NPM-MLF1 chimera generated by the t(3;5) associated with myelodysplastic syndrome and acute myeloid leukemia.
|
9328447 |
1997 |
Adult Myelodysplastic Syndrome
|
0.060 |
GeneticVariation
|
disease |
BEFREE |
MNDA binds NPM/B23 and the NPM-MLF1 chimera generated by the t(3;5) associated with myelodysplastic syndrome and acute myeloid leukemia.
|
9328447 |
1997 |
leukemia
|
0.040 |
GeneticVariation
|
disease |
BEFREE |
Three reciprocal chromosome translocations found in certain cases of leukemia/lymphoma involve fusions with the NPM/B23 gene, t(5;17) NPM-RARalpha, t(2;5) NPM-ALK, and the t(3;5) NPM-MLF1.
|
9328447 |
1997 |
Childhood Leukemia
|
0.040 |
GeneticVariation
|
disease |
BEFREE |
Three reciprocal chromosome translocations found in certain cases of leukemia/lymphoma involve fusions with the NPM/B23 gene, t(5;17) NPM-RARalpha, t(2;5) NPM-ALK, and the t(3;5) NPM-MLF1.
|
9328447 |
1997 |
Leukemia, Myelocytic, Acute
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Recently, the breakpoints in three pediatric cases of AML M2 with t(3;5) were cloned and shown to involve the myelodysplasia/myeloid leukemia factor I (MLF1) gene on 3q25.1 and the nucleophosmin (NPM) gene on 5q34, generating a chimeric NPM/MLF1 transcript.
|
9595039 |
1998 |
Leukemia, Myelocytic, Acute
|
0.500 |
Biomarker
|
disease |
BEFREE |
These findings provide an NPM-MLF1-mediated novel mechanism of apoptotic induction and imply that NPM-MLFI in collaboration with anti-apoptotic oncoproteins may play an important role in multi-step progression from MDS to AML.
|
10391679 |
1999 |
MYELODYSPLASTIC SYNDROME
|
0.080 |
Biomarker
|
group |
BEFREE |
These findings provide an NPM-MLF1-mediated novel mechanism of apoptotic induction and imply that NPM-MLFI in collaboration with anti-apoptotic oncoproteins may play an important role in multi-step progression from MDS to AML.
|
10391679 |
1999 |
Childhood Myelodysplastic Syndrome
|
0.070 |
Biomarker
|
disease |
BEFREE |
Apoptosis induced by the myelodysplastic syndrome-associated NPM-MLF1 chimeric protein.
|
10391679 |
1999 |
Adult Myelodysplastic Syndrome
|
0.060 |
Biomarker
|
disease |
BEFREE |
Apoptosis induced by the myelodysplastic syndrome-associated NPM-MLF1 chimeric protein.
|
10391679 |
1999 |
Leukemia, Myelocytic, Acute
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
One of the genes isolated (HLS7) is homologous to the novel human oncogene myeloid leukemia factor 1 (MLF1) involved in the t(3;5)(q25.1;q34) translocation associated with acute myeloid leukemia.
|
10523300 |
1999 |